Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(154)
•••
CMHarring218431
X
View Profile
View Bullboard History
Comment by
CMHarring218431
on Apr 10, 2024 8:46am
RE:RE:RE:RE:RE:5:57 EST!
Pre-market is insane! Now, mm's have brought it down to $1.05x $1.05 on 3000 shares traded. Any astute trader care to throw out another opinion
(846)
•••
canadafan
X
View Profile
View Bullboard History
Comment by
canadafan
on Apr 10, 2024 8:32am
RE:RE:RE:RE:5:57 EST!
Thew pre-market, by its own definition can be very spontanious. Could be a good indicator, or just random. This wave , however had some volume to it. Over a 100K shares is not tins, but for ONC
...more
Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
posted May 03, 2024 9:00am by
Pulsar Helium Inc.
-
|
In recognition of the recent docu-film highlighting the importance of helium in healthcare we are offering investors an opportunity to join Pulsar on the ground in Minnesota for this month's historic reservoir flow tests. CLICK HERE ...read more
(454)
•••
Lesalpes29
X
View Profile
View Bullboard History
Comment by
Lesalpes29
on Apr 10, 2024 8:10am
RE:RE:RE:5:57 EST!
Premarket shares traded at 196k. Now sp is red! Stay tuned.
(454)
•••
Lesalpes29
X
View Profile
View Bullboard History
Comment by
Lesalpes29
on Apr 10, 2024 6:48am
RE:RE:5:57 EST!
Shortly it will be 100k shares traded during premarket. Good news to come I hope. Making unstable smilling lol.
(154)
•••
CMHarring218431
X
View Profile
View Bullboard History
Comment by
CMHarring218431
on Apr 10, 2024 6:16am
RE:5:57 EST!
Volume 96000 shares on Nasdaq.If real, at 6:00....we might have ourselves some big action today! Up 10 cents!
(454)
•••
Lesalpes29
X
View Profile
View Bullboard History
Post by
Lesalpes29
on Apr 10, 2024 5:58am
5:57 EST!
Active premarket this morning! Have a good day.
(5027)
•••
Noteable
X
View Profile
View Bullboard History
Post by
Noteable
on Apr 09, 2024 3:49pm
AACR24: double-stranded RNA that mimics viral activity
April 08, 2024 - a double-stranded RNA that mimics viral activity, thereby stimulating the immune response, turns cold prostate cancer cells hot. By comparison ONCY's oncolytic virus
...more
(5027)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 09, 2024 3:11pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration
So .... among other things, intratumoral (IT) injection has not been used in routine clinical practice. Firstly, the safety of an intratumoral procedure is a prime concern in identifying lesions that
...more
(5027)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 09, 2024 10:42am
RE:RE:RE:AstraZeneca's ADC disappoints - on severe adverse events
April 09, 2024 - AACR24 - An AACR poster on Vincerx's VIP236, a small-molecule drug conjugate that targets αvβ3 and is the company’s most advanced asset, has revealed zero objective
...more
(5027)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 09, 2024 9:31am
RE:“Second mouse gets the cheese “
Could Matt Coffey have been referring to the BioNTech / Genentech mRNA + atezolizumab combination in the treatment of resectable pancreatic cancer as the first mouse? https://stockhouse.com/companies
...more
(1191)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 09, 2024 6:15am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration
Haha some one got a lil defensive. How many days you pore over this diatribe? I love that you're having to use the ole "buy the dip" defense for Crispy. So your trading it or are you
...more
(5027)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 08, 2024 9:13pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration
Additionally, and as importantly, ONCY's oncolytic virus pelareorep is administered through intravenous (IV) injection rather than intratumoral (IT) injection, which is the route most other
...more
(5027)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 08, 2024 8:50pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration
Should read: crispr stock is down to $64 from a high of $200.
(5027)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 08, 2024 8:49pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration
BTW crispr stick is down to $64 from its high of $200 in Jan 2021. Just sayin' that health technology often takes time to prove itself, particularly if it is innovative and novel. And cell and
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company